Our client wishes to acquire injectable products that are currently marketed in Germany.

  • Anesthetics / analgesics are preferred, but other therapeutic areas may be acceptable.
  • Pharmaceutical products are preferred, but drug/device combinations may be acceptable.

Products need to be injectables primarily used in secondary care or as hospital products.

Suitable partners may be located outside of Germany.

Candidate products should have €5M-30M annual turnover, however €1M-5M opportunities may also be considered with lower priority.

Additionally, companies marketing injectable products in Spain may also be of interest for acquisition.